De Biofisiofarmacologia, Campo Grande, MS, Brasil 4 Universidade Federal de Mato Grosso do Sul, Centro de Ci cias Biol icas e da Sa e, Laborat io de Tecnologia Farmac tica, Campo Grande, MS, Brasil 5Universidade Federal de Mato Grosso do Sul, Centro de Ci cias Biol icas e da Sa e, Laborat io de Biologia Molecular e Culturas Celulares, Campo Grande, MS, BrasilThe polar hydroethanolic extract from Selaginella sellowii (SSPHE) has been previously confirmed active on intracellular amastigotes (in vitro test) and now was tested on hamsters infected with Leishmania (Leishmania) amazonensis (in vivo test). SSPHE suppressed a one hundred from the parasite load in the infection web site and draining lymph nodes at an intralesional dose of 50 mg/kg/day five, which was similar for the outcomes observed in hamsters treated with N-methylglucamine antimonate (Sb) (28 mg/Kg/day five). When orally administered, SSPHE (50 mg/kg/day 20) suppressed 99.2 in the parasite load in infected footpads, though Sb suppressed 98.5 . SSPHE also enhanced the release of nitric oxide through the intralesional route in comparison to Sb.BuyN-Methyl-L-valine The chemical fingerprint of SSPHE by high-performance liquid chromatography with diode-array detection and tandem mass spectrometry showed the presence of biflavonoids and high molecular weight phenylpropanoid glycosides. These compounds may have a synergistic action in vivo. Histopathological study revealed that the intralesional treatment with SSPHE induced an intense inflammatory infiltrate, composed primarily of mononuclear cells. The present findings reinforce the prospective of this all-natural item as a source of future drug candidates for American cutaneous leishmaniasis.Key words: antileishmanial activity – plant extracts – all-natural products – experimental leishmaniasisAmerican cutaneous leishmaniasis (ACL) is an infectious, noncontagious disease caused by different species of protozoa on the genus Leishmania Ross, 1903, that affects the skin, cartilage, and mucous membranes from the upper respiratory tract (Reithinger et al.24294-89-1 uses 2007).PMID:24428212 Drugs used within the treatment of leishmaniasis have a variety of drawbacks, for instance high degrees of toxicity, the improvement of resistance on the part of the parasite, and high fees (Santos et al. 2008). Pentavalent antimonials are the initially choice for treatment although other drugs, for instance pentamidine, amphotericin B, and paromomycin are utilised as a second solution in resistant situations, despite the considerable degree of toxicity for the host (Mitropoulos et al. 2010). Numerous plant-derived extracts happen to be tested in experimental leishmaniasis, searching for the much better effects and much less toxicity showed by these natural solutions (Fournet et al. 1996, Pontin et al. 2008, Ezatpour et al.2015). Distinct secondary metabolites with considerable structural range have demonstrated antileishmanial activity whilst providing a low degree of toxicity and allowing other forms of administration, such as derivatives of hydroquinones, naphthoquinones, terpenoids, flavonoids, alkaloids, and lignans (Fournet Mu z 2002). Recently, the hydroethanolic extract from Selaginella sellowii was verified active on Leishmania (Leishmania) amazonensis intracellular amastigotes (Rizk et al. 2014). This noncytotoxic extract contained amentoflavone and robustaflavone, two compounds with the most important bioactive class in Selaginella genus, the biflavonoids (Lin et al. 1994, Silva et al. 1995, Sun et al. 1997, Aguilar et al. 2008, 2013, Lee et al. 2008). The aim of the present st.